TD Asset Management
OCUL icon

TD Asset Management’s Ocular Therapeutix OCUL Stock Holding History

TD Asset Management’s Portfolio OCUL Stock Details OCUL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.02M Buy
+238,000
New +$2.27M ﹤0.01% 964
2025
Q1 		– Sell
-60,000
Closed -$512K – 1253
2024
Q4 		$512K Sell
60,000
-52,800
-47% -$515K ﹤0.01% 1184
2024
Q3 		$979K Hold
112,800
– – ﹤0.01% 1188
2024
Q2 		$772K Buy
112,800
+32,400
+40% +$200K ﹤0.01% 1205
2024
Q1 		$732K Buy
+80,400
New +$571K ﹤0.01% 1237

Other funds holding OCUL

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $4.85B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SR
Summer Road West Palm Beach, Florida $142M AUM 43.61% 1-Year Est. Return
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $57.5B AUM 55.25% 1-Year Est. Return